The short version
6 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Fosphenytoin sodium
Fosphenytoin sodium · FOSPHENYTOIN SODIUM 50 mg/mL · Injection, Solution · Intramuscular; Intravenous · Glenmark Pharmaceuticals Inc., Usa
NDC 68462-0622-64 · 10 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$230.74
Reported to Texas DSHS · 2026 annual filing · Glenmark Pharmaceuticals Inc., USA
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- Gland Pharma LimitedIndiaanalysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $170.71 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA214926
- TE code
- AP
- Approval date
- Oct 13, 2023
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Fosphenytoin sodium (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Gland Pharma Limited | FOSPHENYTOIN SODIUM 50 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Pfizer Laboratories Div Pfizer Inc | FOSPHENYTOIN SODIUM 50 mg/mL | Jul 15, 2026 | Sep 3, 2026 |
| Fresenius Kabi USA, LLC | FOSPHENYTOIN SODIUM 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Sagent Pharmaceuticals | FOSPHENYTOIN SODIUM 50 mg/mL | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., Usa | FOSPHENYTOIN SODIUM 50 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
| West-Ward Pharmaceuticals Corp | FOSPHENYTOIN SODIUM 50 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Fosphenytoin sodium — NDC 68462-0622-64," retrieved September 3, 2026, https://drugdashboards.com/drug/68462062264.
Free to cite with attribution — see how the data is put together.